{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:13:14Z","timestamp":1773249194193,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Hypertension affects at least 80% of hemodialysis patients. Inappropriate control of blood pressure is mentioned as one of the essential cardiovascular risk factors associated with development of cardiovascular events in dialysis populations. The aim of the cross-sectional, retrospective study was the evaluation of the antihypertensive treatment schedule and control of blood pressure in relation to the guidelines in the group of hemodialysis patients. Additionally, we assessed the level of decrease in blood pressure by each group of hypotensive agents. Materials and Methods: 222 patients hemodialyzed in a single Dialysis Unit in three distinct periods of time\u20142006, 2011, and 2016\u2014with a diagnosis of hypertension were enrolled in the study. The analysis of the antihypertensive treatment was based on the medical files and it consisted of a comparison of the mean blood pressure results reported during the six consecutive hemodialysis sessions. Results: The mean values of blood pressure before hemodialysis were as follows: 134\/77, 130\/74, and 140\/76 mmHg, after hemodialysis 124\/74, 126\/73, and 139\/77 mmHg in 2006, 2011, and 2016 respectively. The goal of predialysis blood pressure control (&lt;140\/90) was achieved by up to 64.3% of participants in 2006 as compared to 49.4% in 2016. Additionally, the postdialysis goal (&lt;130\/90) reached 57.1% of the study population in 2006 as compared to 27.1% of patients in 2016. The differences in percentage of patients using single, double, triple, and multidrug therapy during observation were not statistically significant. The most often used drugs were \u00df-blockers, diuretics, and calcium channel blockers in all points of the study. Blockades of the renin\u2013angiotensin\u2013aldosterone system in 2006 and calcium channel blockers in 2011 and 2016 were the drugs with highest impact on lowering blood pressure. Conclusions: The goal of predialysis or postdialysis blood pressure control was achieved in a lower percentage of patients during the period of the study. Blockade of renin\u2013angiotensin\u2013aldosterone system and calcium channel blockers decrease the blood pressure significantly. It is necessary to achieve better control of blood pressure in prevention of cardiovascular incidents.<\/jats:p>","DOI":"10.3390\/medicina57060590","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T12:08:55Z","timestamp":1623154135000},"page":"590","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients\u2014Retrospective Single Center Experience"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1862-6610","authenticated-orcid":false,"given":"Piotr","family":"Skonieczny","sequence":"first","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3284-0149","authenticated-orcid":false,"given":"Zbigniew","family":"Heleniak","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Karowiec","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-7368","authenticated-orcid":false,"given":"Stanis\u0142aw","family":"Zaj\u0105czkowski","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-5072","authenticated-orcid":false,"given":"Leszek","family":"Tylicki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8210-8063","authenticated-orcid":false,"given":"Alicja","family":"D\u0119bska-\u015alizie\u0144","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-3634","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Department of Internal and Pediatric Nursing, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"},{"name":"Diaverum Dialysis Center, 80-104 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/ajkd.2002.30542","article-title":"Hemodialysis-associated hypertension: Pathophysiology a therapy","volume":"39","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(09)60212-9","article-title":"Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: A systemic review and meta-analysis of randomized controlled trials","volume":"373","author":"Heerspink","year":"2009","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"iii62","DOI":"10.1093\/ndt\/gfh1018","article-title":"Epidemiology of arterial hypertension in renal transplant patients: Changes over the last decade","volume":"19","author":"Campistol","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ackd.2010.11.001","article-title":"Hypertension in moderate-to-severe nondiabetic CKD patients","volume":"18","author":"Segura","year":"2011","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1755.61.s80.28.x","article-title":"Kidney and hypertension","volume":"80","author":"Adamczak","year":"2002","journal-title":"Kidney Int."},{"key":"ref_6","first-page":"202","article-title":"Treatment of hypertension in patients with chronic kidney disease according to the newest guidelines","volume":"12","author":"Skonieczny","year":"2019","journal-title":"Forum Nefrologiczne"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11906-009-0049-y","article-title":"Management of hypertension in hemodialysis patients","volume":"11","author":"Ram","year":"2009","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_8","first-page":"239","article-title":"Cardiovascular disease and mortality in ESRD","volume":"11","author":"Foley","year":"1998","journal-title":"J. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000070987","article-title":"Hypertension and dialysis","volume":"26","year":"2003","journal-title":"Kidney Blood Press. Res."},{"key":"ref_10","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","author":"Workgroup","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_11","first-page":"2159","article-title":"2013 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Bryan","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000331067","article-title":"Epidemiology of interdialytic ambulatory hypertension and the role of volume excess","volume":"34","author":"Agarwal","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ki.2009.469","article-title":"Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"77","author":"Levin","year":"2010","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11255-020-02461-7","article-title":"Interleukin 6 is a better predictor of 5-year cardiovascular mortality than high-sensitivity C-reactive protein in hemodialysis patients using reused low-flux dialyzers","volume":"52","author":"Thang","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HJH.0000000000000447","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs\u2014Overview and meta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2215\/CJN.04330418","article-title":"Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in Chronic Kidney Disease","volume":"14","author":"Sinha","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/sdi.12691","article-title":"Beta blockers in patients with end-stage renal disease-Evidence-based recommendations","volume":"31","author":"Weir","year":"2018","journal-title":"Semin. Dial."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ajkd.2006.12.012","article-title":"Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS)","volume":"49","author":"Fissell","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.0894-0959.2004.17329.x","article-title":"Drug therapy for hypertension in hemodialysis patients","volume":"17","year":"2004","journal-title":"Semin. Dial."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/ndt\/gfm805","article-title":"Acute effects of low and high intravenous doses of furosemide on myocardial function in anuric haemodialysis patients: A tissue Doppler study","volume":"23","author":"Hayashi","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2215\/CJN.01760210","article-title":"Dry-weight: A concept revisited in an effort to avoid medication directed approaches for blood pressure control in hemodialysis patients","volume":"5","author":"Agarwal","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1046\/j.1523-1755.2001.00745.x","article-title":"Add-on angiotensin receptor blockade with maximized ACE inhibition","volume":"59","author":"Agarwal","year":"2001","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1159\/000485433","article-title":"N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients","volume":"42","author":"Wyskida","year":"2017","journal-title":"Kidney Blood Press Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.ajkd.2006.07.005","article-title":"The epidemiology of systolic blood pressure and death risk in hemodialysis patients","volume":"48","author":"Li","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.287.12.1548","article-title":"Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis","volume":"287","author":"Klassen","year":"2002","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MNH.0b013e32833f0d82","article-title":"Blood pressure management in hemodialysis: What have we learned?","volume":"19","author":"Peixoto","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1523-1755.1998.00005.x","article-title":"\u201cU\u201d curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic","volume":"54","author":"Zager","year":"1998","journal-title":"In. Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08037051.2014.986931","article-title":"Treatment of hypertension in chronic kidney disease patients under specialized care: One-center cross-sectional analyses","volume":"24","author":"Tylicki","year":"2015","journal-title":"Blood Press"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5603\/KP.2013.0066","article-title":"Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey","volume":"71","author":"Zdrojewski","year":"2013","journal-title":"Kardiol. Pol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/590\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:04Z","timestamp":1760163124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["medicina57060590"],"URL":"https:\/\/doi.org\/10.3390\/medicina57060590","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}